Question to the Department of Health and Social Care:

To ask His Majesty's Government whether the national supply disruption problems of the most used ADHD medications have been resolved, and if not, what are the causes and when they expect the supply to return to acceptable levels.

Disruptions to the supply of medicines used for the management of attention deficit and hyperactivity disorder (ADHD) have been primarily driven by issues which have resulted in capacity constraints at key manufacturing sites. The Department has been working closely with the respective manufacturers and some issues have now been resolved. However, we know that there continue to be disruptions to the supply of some other medicines, which should resolve by April 2024.

We have well-established processes to manage supply issues and continue to work with the respective manufacturers and all relevant stakeholders to ensure that the supply disruptions are resolved as soon as possible.

We understand how frustrating and distressing medicine shortages can be and we want to assure patients that we are working with the respective manufacturers to resolve the issues with ADHD medicine supply in the United Kingdom as soon as possible and to help ensure patients are able to access these medicines in the short and long term.